What is GHK-Cu used for?
GHK-Cu is used in preclinical research across dermal wound-healing, skin-regeneration, hair-follicle, anti-oxidative-stress, and gene-expression research contexts. The Pickart-group synthesis literature spans more than four decades of accumulated research on the copper-peptide pharmacology.
What the research literature says
GHK-Cu’s research applications cluster around the copper-dependent signalling pharmacology characterised in the Conato coordination-chemistry work (PMID 11325542) and elaborated across the Pickart synthesis literature. The dermal-research framework is anchored by the Kang keratinocyte work documenting integrin expression and p63 transcription-factor positivity (PMID 19319546). The Pickart tissue-remodelling synthesis frames GHK as a natural modulator of wound-healing (PMID 18644225).
The skin-regeneration applications are consolidated in the Pickart natural-modulator synthesis (PMID 26236730) and the 2018 regenerative-actions review integrating gene-expression data (PMID 29986520). The Pickart oxidative-stress and cognitive-health work extends the framework into anti-aging and neural research contexts (PMID 22666519, PMID 28212278).
Copper-free GHK (without the Cu(II) chelate) has distinguishable activity. The Choi stem-cell-recovering work (PMID 23019153) and the Beretta 4-hydroxy-2-nonenal-quenching work (PMID 17672515) characterise copper-independent pharmacology relevant to specific research contexts. The Ronin catalog supplies the copper-complexed GHK-Cu form as the bioactive species used across most published dermal and skin-regeneration research.
Why this matters in research context
GHK-Cu’s research applications span more cell types and tissue contexts than the receptor-targeted peptides because the copper-delivery and redox-active properties operate across diverse cellular environments. Researchers selecting GHK-Cu should anchor protocol design to the specific Pickart-group literature most relevant to the experimental question — dermal/keratinocyte/fibroblast for skin research, oxidative-stress for anti-aging contexts, gene-expression for transcriptional-modulation work.
Related compounds
- GHK-Cu 50mg — the compound covered by this answer
- Glow Blend — three-compound formulation including GHK-Cu
- KLOW Blend — four-compound formulation including GHK-Cu
Related research questions
References
- Conato C et al. Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity. Biochim Biophys Acta 2001;1526(2):199-210. [PMID 11325542]
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed 2008;19(8):969-988. [PMID 18644225]
- Kang YA et al. Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Arch Dermatol Res 2009;301(4):301-306. [PMID 19319546]
- Pickart L et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int 2015;2015:648108. [PMID 26236730]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. GHK-Cu is sold strictly as a research-grade reagent for laboratory and bench research applications.